- Home
- BBIO vs EPAM Comparison
BBIO vs EPAM Comparison
Compare BBIO & EPAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- EPAM
- Stock Information
- Founded
- BBIO 2015
- EPAM 1993
- Country
- BBIO United States
- EPAM United States
- Employees
- BBIO N/A
- EPAM N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- EPAM EDP Services
- Sector
- BBIO Health Care
- EPAM Technology
- Exchange
- BBIO Nasdaq
- EPAM Nasdaq
- Market Cap
- BBIO 12.5B
- EPAM 10.2B
- IPO Year
- BBIO 2019
- EPAM 2012
- Fundamental
- Price
- BBIO $71.90
- EPAM $186.25
- Analyst Decision
- BBIO Strong Buy
- EPAM Buy
- Analyst Count
- BBIO 19
- EPAM 14
- Target Price
- BBIO $74.79
- EPAM $217.50
- AVG Volume (30 Days)
- BBIO 2.4M
- EPAM 1.1M
- Earning Date
- BBIO 10-29-2025
- EPAM 11-06-2025
- Dividend Yield
- BBIO N/A
- EPAM N/A
- EPS Growth
- BBIO N/A
- EPAM N/A
- EPS
- BBIO N/A
- EPAM 6.55
- Revenue
- BBIO $353,780,000.00
- EPAM $5,297,859,000.00
- Revenue This Year
- BBIO $123.32
- EPAM $16.65
- Revenue Next Year
- BBIO $73.46
- EPAM $7.20
- P/E Ratio
- BBIO N/A
- EPAM $28.19
- Revenue Growth
- BBIO 62.46
- EPAM 14.26
- 52 Week Low
- BBIO $25.34
- EPAM $138.15
- 52 Week High
- BBIO $72.26
- EPAM $269.00
- Technical
- Relative Strength Index (RSI)
- BBIO 71.58
- EPAM 71.22
- Support Level
- BBIO $64.41
- EPAM $176.25
- Resistance Level
- BBIO $67.71
- EPAM $187.17
- Average True Range (ATR)
- BBIO 2.80
- EPAM 5.86
- MACD
- BBIO 0.35
- EPAM 0.42
- Stochastic Oscillator
- BBIO 95.73
- EPAM 95.45
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About EPAM EPAM Systems Inc.
EPAM Systems is a global IT services firm with a focus on platform engineering, software development, and consulting services. The company used to host large engineer bases in Ukraine, Belarus, and Russia, but it now delivers from various locations across different continents. EPAM's largest market is North America, which represents approximately 60% of revenue.